DT
IMGN

Diversified Trust’s Immunogen Inc IMGN Stock Holding History

Diversified Trust’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-33,394
Closed -$990K – 960
2023
Q4 		$990K Sell
33,394
-9,123
-21% -$182K 0.03% 293
2023
Q3 		$675K Buy
42,517
+1,798
+4% +$29.9K 0.03% 360
2023
Q2 		$768K Buy
40,719
+1,614
+4% +$19.1K 0.03% 344
2023
Q1 		$150K Hold
39,105
– – 0.01% 771
2022
Q4 		$194K Hold
39,105
– – 0.01% 730
2022
Q3 		$187K Sell
39,105
-2,072
-5% -$10.9K 0.01% 708
2022
Q2 		$185K Hold
41,177
– – 0.01% 694
2022
Q1 		$196K Hold
41,177
– – 0.01% 753
2021
Q4 		$306K Buy
41,177
+3,617
+10% +$22.5K 0.01% 630
2021
Q3 		$213K Hold
37,560
– – 0.01% 704
2021
Q2 		$248K Buy
37,560
+1,749
+5% +$12.2K 0.01% 619
2021
Q1 		$290K Sell
35,811
-5,553
-13% -$45.3K 0.01% 549
2020
Q4 		$267K Buy
41,364
+7,952
+24% +$46.4K 0.01% 560
2020
Q3 		$120K Hold
33,412
– – 0.01% 605
2020
Q2 		$154K Buy
+33,412
New +$142K 0.01% 509

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Diversified Trust's IMGN Position: Q1 2024 in Review

Diversified Trust sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 33,394 shares — an estimated $990K sold.

Diversified Trust first reported a position in IMGN in Q2 2020 and held it in 15 quarters. The position peaked at $990K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Diversified Trust reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Diversified Trust sold 33,394 Immunogen Inc shares in Q1 2024, an estimated $990K.
  • Diversified Trust first reported a position in Immunogen Inc in Q2 2020 and held it in 15 quarters.
  • Diversified Trust's Immunogen Inc position peaked at $990K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Diversified Trust's 13F filing for Q1 2024, filed 18 Apr 2024.